Ate J. Van Der Zee

FIGO 2021 depth of invasion measurement and missed lymph node involvement in microinvasive vulvar squamous cell carcinoma: Is the gain worth the cost?

Journal: European journal of cancer (Oxford, England : 1990)

Published: January 13, 2026

PAX1 and ZNF582 Methylation as a Triage Strategy in Cytologic and hrHPV+ Scrapings in Both Chinese and Dutch Cohorts.

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Published: January 04, 2026

Establishment and characterization of ovarian clear cell carcinoma patient-derived xenografts.

Journal: Scientific reports

Published: September 09, 2024

European Society of Gynaecological Oncology Guidelines for the Management of Patients with Vulvar Cancer - Update 2023.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: June 27, 2023

Phase II activity trial of high-dose radiation and chemosensitization in patients with macrometastatic lymph node spread after sentinel node biopsy in vulvar cancer: GROningen INternational Study on Sentinel nodes in Vulvar cancer III (GROINSS-V III/NRG-GY024).

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: January 18, 2023

History and Updates of the GROINSS-V Studies.

Journal: Cancers

Published: January 31, 2022

Radiotherapy Versus Inguinofemoral Lymphadenectomy as Treatment for Vulvar Cancer Patients With Micrometastases in the Sentinel Node: Results of GROINSS-V II.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: August 25, 2021

Low-dose triple drug combination targeting the PI3K/AKT/mTOR pathway and the MAPK pathway is an effective approach in ovarian clear cell carcinoma.

Journal: Cancer letters

Published: May 22, 2019

FIGO 2021 depth of invasion measurement and missed lymph node involvement in microinvasive vulvar squamous cell carcinoma: Is the gain worth the cost?

FIGO 2021 depth of invasion measurement and missed lymph node involvement in microinvasive vulvar squamous cell carcinoma: Is the gain worth the cost?

PAX1 and ZNF582 Methylation as a Triage Strategy in Cytologic and hrHPV+ Scrapings in Both Chinese and Dutch Cohorts.

PAX1 and ZNF582 Methylation as a Triage Strategy in Cytologic and hrHPV+ Scrapings in Both Chinese and Dutch Cohorts.

Establishment and characterization of ovarian clear cell carcinoma patient-derived xenografts.

Establishment and characterization of ovarian clear cell carcinoma patient-derived xenografts.

European Society of Gynaecological Oncology Guidelines for the Management of Patients with Vulvar Cancer - Update 2023.

European Society of Gynaecological Oncology Guidelines for the Management of Patients with Vulvar Cancer - Update 2023.

Phase II activity trial of high-dose radiation and chemosensitization in patients with macrometastatic lymph node spread after sentinel node biopsy in vulvar cancer: GROningen INternational Study on Sentinel nodes in Vulvar cancer III (GROINSS-V III/NRG-GY024).

Phase II activity trial of high-dose radiation and chemosensitization in patients with macrometastatic lymph node spread after sentinel node biopsy in vulvar cancer: GROningen INternational Study on Sentinel nodes in Vulvar cancer III (GROINSS-V III/NRG-GY024).

History and Updates of the GROINSS-V Studies.

History and Updates of the GROINSS-V Studies.

Radiotherapy Versus Inguinofemoral Lymphadenectomy as Treatment for Vulvar Cancer Patients With Micrometastases in the Sentinel Node: Results of GROINSS-V II.

Radiotherapy Versus Inguinofemoral Lymphadenectomy as Treatment for Vulvar Cancer Patients With Micrometastases in the Sentinel Node: Results of GROINSS-V II.

DNA methylation markers as triage test for the early identification of cervical lesions in a Chinese population.

DNA methylation markers as triage test for the early identification of cervical lesions in a Chinese population.

First-in-Human Phase I Clinical Trial of an SFV-Based RNA Replicon Cancer Vaccine against HPV-Induced Cancers.

First-in-Human Phase I Clinical Trial of an SFV-Based RNA Replicon Cancer Vaccine against HPV-Induced Cancers.

Radical vulvectomy with right gluteal and left medial thigh V-Y advancement flap reconstruction

Radical vulvectomy with right gluteal and left medial thigh V-Y advancement flap reconstruction

Kinome capture sequencing of high-grade serous ovarian carcinoma reveals novel mutations in the JAK3 gene.

Kinome capture sequencing of high-grade serous ovarian carcinoma reveals novel mutations in the JAK3 gene.

Low-dose triple drug combination targeting the PI3K/AKT/mTOR pathway and the MAPK pathway is an effective approach in ovarian clear cell carcinoma.

Low-dose triple drug combination targeting the PI3K/AKT/mTOR pathway and the MAPK pathway is an effective approach in ovarian clear cell carcinoma.